Article metrics

Download PDFPDF

Correction: Survival outcomes and independent response assessment with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma: 42-month follow-up of a randomized phase 3 clinical trial

 

Online download statistics by month:

Online download statistics by month: to

AbstractFullPdf
Total000